Inhibitors of DNA double-strand break repair at the crossroads of cancer therapy and genome editing-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibitors of DNA double-strand break repair at the crossroads of cancer therapy and genome editing

Published:2020-12 Issue: Volume:182 Page:114195
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Ray Ujjayinee,Raghavan Sathees C.

Funder

Council of Scientific and Industrial Research, India

Department of Atomic Energy, Government of India

Indo-French Centre for the Promotion of Advanced Research

Department of Biotechnology, Ministry of Science and Technology, India

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference184 articles.

1. BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair;Abbott;J. Biol. Chem.,1999

2. Coordination of DNA single strand break repair;Abbotts;Free Radical Biol. Med.,2017

3. Molecular disruption of RAD50 sensitizes human tumor cells to cisplatin-based chemotherapy;Abuzeid;J. Clin. Investig.,2009

4. Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations;Alano;PNAS,2006

5. Linking off-target kinase pharmacology to the differential cellular effects observed among PARP inhibitors;Antolin;Oncotarget,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and Synthesis of Ketenimine Sulfonamide Conjugates through Multicomponent Reactions; A Combined Cytotoxic Analysis and Computational Exploration;ACS Omega;2023-10-05

2. Enhancing the anti-tumor response by combining DNA damage repair inhibitors in the treatment of solid tumors;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-07

3. Nonhomologous DNA End Joining in Mammalian Cells;Encyclopedia of Cell Biology;2023

4. ML216-Induced BLM Helicase Inhibition Sensitizes PCa Cells to the DNA-Crosslinking Agent Cisplatin;Molecules;2022-12-12

5. Identification and characterization of mercaptopyrimidine‐based small molecules as inhibitors of nonhomologous DNA end joining;The FEBS Journal;2022-09-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3